| アブストラクト | BACKGROUND: There is increasing evidence that vitamin D supplementation may only be beneficial in people with vitamin D deficiency, and the lack of sufficient people with very low vitamin D levels could explain the lack of protection against cardiovascular disease (CVD) reported in recent clinical trials of vitamin D supplementation. The aim of this study was to assess associations of low to moderate circulating concentrations of 25-hydroxyvitamin D (25(OH)D with risk of incident CVD and all-cause mortality, as well as the risk of ischaemic heart disease (IHD), cerebrovascular disease, and heart failure separately. METHODS AND RESULTS: Longitudinal analysis of electronic health records in The Health Improvement Network (THIN), a UK primary care database. The analysis included 180,263 patients age 18 years and older without a history of CVD and with circulating concentrations of 25(OH)D. After a mean follow-up of 2.2 (SD 1.7) years, there were 3747 patients diagnosed with CVD and 3912 patients died. Compared to patients in the highest quintile of 25(OHD) (>/= 67.5nmol/L), those in the lowest 25(OH)D quintile (<23.1nmol/L) had a hazard ratio (HR) of 1.24 (95% CI 1.12-1.38, P< 0.001) for CVD and 1.71 (1.55-1.88, P< 0.001) for mortality. The HR for both outcomes associated with 25(OH)D concentration was non-linear, being significantly increased in patients with 25(OH)D <35 nmol/L, and highest in those with 25(OH)D <25 nmol/L, although increased for mortality at 25(OH)D >/=100 nmol/L. The increased CVD HR in the lowest 25(OH)D quintile was more from IHD (1.35, 95% CI 1.13-1.60) and heart failure (1.38, 95% CI 1.08-1.77), than from cerebrovascular disease (1.13, 95% CI 0.97-1.31). CONCLUSION: Low 25(OH)D are associated with highest risk of CVD and mortality, and are consistent with accumulating evidence that increased risk of these diseases occurs primarily in people with vitamin D deficiency. |
|---|
| ジャーナル名 | The Journal of steroid biochemistry and molecular biology |
|---|
| Pubmed追加日 | 2019/9/22 |
|---|
| 投稿者 | Crowe, Francesca L; Thayakaran, Rasiah; Gittoes, Neil; Hewison, Martin; Thomas, G Neil; Scragg, Robert; Nirantharakumar, Krishnarajah |
|---|
| 組織名 | Institute of Applied Health Research, College of Medical and Dental Sciences,;University of Birmingham, Birmingham, UK.;Institute of Metabolism and Systems Research, College of Medical and Dental;Sciences, University of Birmingham, Birmingham, UK; Centre for Endocrinology,;Diabetes and Metabolism, College of Medical and Dental Sciences, University of;Birmingham, Birmingham, UK.;Sciences, University of Birmingham, Birmingham, UK.;School of Population Health, Faculty of Medical and Health Sciences, University;of Auckland, Auckland, New Zealand. Electronic address: r.scragg@auckland.ac.nz.;University of Birmingham, Birmingham, UK. Electronic address:;K.Nirantharan@bham.ac.uk. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/31541727/ |
|---|
